Skip to main content
. 2020 Jan 6;111(2):182–192. doi: 10.17269/s41997-019-00275-4

Table 3.

IMD costs and disutilities

Complication Direct medical costsa Sources Productivity costsa Sources Disutility Sources
Uncomplicated disease $14,918 $2988 De Wals et al. (2007) − 0.0317b Ginsberg et al. (2016)
Scarring $9347 OCCI (2016) $0 Assumed − 0.08 Bijlard et al. (2017)
Amputation $22,070 OCCI (2016)

≤ 24 years: $244,136c

25–59 years: $136,124

≥ 60 years: $14,493

Rancourt et al. (2003) − 0.32 Shepard et al. (2005)
Paralysis $6559 OCCI (2016) $0 No data available − 0.32 Assumed equal to amputation
Seizure/epilepsy $11,028 OCCI (2016) $0 No data available − 0.053 Ginsberg et al. (2016)
Hearing loss $0 No data available $64,758d Chen et al. (2014) − 0.033 Ginsberg et al. (2016)
Neurologic sequelae $8743 OCCI (2016)

≤ 24: $1,220,682e

25–59: $680,621

≥ 60: $72,463

Shepard et al. (2005) − 0.56 Oostenbrink et al. (2002)
Renal failure $12,047 OCCI (2016) $0 No data available − 0.107 Ginsberg et al. (2016); Murray and Lopez (1996)
Death $0

≤ 24: $1,220,682f

25–59: $680,621

≥ 60: $72,463

Gu and Wong (2010) − 1

aCosts reported in 2015 Canadian dollars

bAcute disutility; all IMD complications are assumed to have lifelong disutility

c20% of lifetime productivity loss

dUnilateral cochlear implant cost (surgical, preoperative, and postoperative) with 25-year time horizon

e100% of lifetime productivity loss

fLifetime productivity loss